Indicated for: multiple sclerosis
Substance: fingolimoda (S1P receptor modulator)
ATC: L04AE01 (Antineoplastic and immunomodulating agents | Immunosuppressants | Sphingosine-1-phosphate (S1P) receptor modulators)
Fingolimod is a medication used to treat multiple sclerosis, an autoimmune disease that affects the central nervous system. This medicine helps reduce the frequency of relapses and slow the progression of the disease, protecting nerve fibers from damage. Fingolimod works by modulating the immune system, preventing immune cells from attacking the nervous system.
Fingolimod is usually taken as capsules once a day, as directed by your doctor. Before starting treatment, a thorough medical evaluation is necessary, and regular check-ups are recommended during therapy to monitor effects and possible side effects.
Common side effects of fingolimod may include headache, fatigue, respiratory infections, increased liver enzyme levels, or digestive problems. In rare cases, more serious reactions may occur, such as heart rhythm disturbances, severe infections, or eye problems. If you experience any unusual symptoms, contact your doctor immediately.
Fingolimod is a modern medicine that has significantly improved the quality of life for patients with multiple sclerosis. Following medical advice and careful monitoring are essential for the safety and effectiveness of the treatment. Inform your doctor about any other medications or supplements you are taking.